Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
10 studies found for:    "Schizophrenia, Paranoid"
Show Display Options
Rank Status Study
1 Unknown  Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Conditions: Schizophrenia, Catatonic;   Schizophrenia, Disorganized;   Schizophrenia, Paranoid;   Schizophrenia;   Psychotic Disorders
Intervention: Drug: Long-acting Risperidone microspheres injection
2 Completed
Has Results
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Intervention: Drug: asenapine
3 Completed
Has Results
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Interventions: Drug: asenapine 2.5 mg;   Drug: asenapine 5.0 mg;   Drug: placebo
4 Completed
Has Results
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition: Paranoid Schizophrenia
Interventions: Drug: MK0249;   Drug: Comparator: Placebo (unspecified)
5 Completed MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
Conditions: Paranoid Schizophrenia;   Schizophrenia
Interventions: Drug: MK0557;   Drug: Comparator: Placebo (unspecified)
6 Recruiting Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychotic Disorder
Intervention: Drug: Risperidone/Olanzapine and PET scans
7 Unknown  Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
Conditions: Psychotic Disorders;   Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder;   Schizophreniform Disorder
Intervention: Behavioral: modified cognitive behavioural therapy (mCBT)
8 Active, not recruiting Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychosis
Intervention: Behavioral: Multi-element, team-oriented treatment
9 Completed
Has Results
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Behavioral: Cognitive Behavioral Therapy
10 Completed Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia
Condition: Schizophrenia
Interventions: Device: t-VNS verum;   Device: t-VNS placebo

Indicates status has not been verified in more than two years